Upregulation of glutathione-related genes and enzyme activities in cultured human cells by sublethal concentrations of inorganic arsenic

Toxicological Sciences

Volumn 70, Issue 2, 2002, Pages 183-192

  Schuliga, Michael ^b   Chouchane, Salem ^a   Snow, Elizabeth T ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenite; Gene expression; Glutathione; Glutathione reductase; Keratinocytes

Indexed keywords

ARSENIC; ARSENOUS ACID DERIVATIVE; CELL ENZYME; CYSTINE; GLUTATHIONE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; INORGANIC COMPOUND; LYASE; MESSENGER RNA;

ACUTE TOXICITY; AMINO ACID TRANSPORT; BREAST TUMOR; CELL CULTURE; CELL LEVEL; CELL LINE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME SYNTHESIS; EXPOSURE; FIBROBLAST; HUMAN; HUMAN CELL; KERATINOCYTE; REVIEW; TIME; TUMOR CELL; UPREGULATION;

ARSENITES; CELL SURVIVAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HUMANS; SODIUM COMPOUNDS; TUMOR CELLS, CULTURED; UP-REGULATION;

EUKARYOTA; MAMMALIA;

EID: 12244310169     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/70.2.183     Document Type: Review

References (53)

1. Allen, R. G., and Tresini, M. (2000). Oxidative stress and gene regulation. Free Radical Biol. Med. 28, 463-499.
2. Anderson, M. E. (1998). Glutathione: An overview of biosynthesis and modulation. Chem. Biol. Interact. 111-112, 1-14.
3. Babich, H., and Borenfreund, E. (1987). Structure activity relationship (SAR) model established in vitro with the neutral red cytotoxicity assay. Toxicol. in Vitro 1, 3-9.
4. Barchowsky, A., Klei, L. R., Dudek, E. J., Swartz, H. M., and James, P. E. (1999a). Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radical Biol. Med. 27, 1405-1412.
5. Barchowsky, A., Roussel, R. R., Klei, L. R., James, P. E., Ganju, N., Smith, K. R., and Dudek, E. J. (1999b). Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways. Toxicol. Appl. Pharmacol. 159, 65-75.
6. Bergelson, S., Pinkus, R., and Daniel, V. (1994). Intracellular glutathione levels regulate Fos/Jun induction and activation of glutathione S-transferase gene expression. Cancer Res. 54, 36-40.
7. Byrd, D. M., Roegner, M. L., Griffiths, J. C., Lamm, S. H., Grumski, K. S., Wilson, R., and Lai, S. (1996). Carcinogenic risks of inorganic arsenic in perspective. Int. Arch. Occup. Environ. Health 68, 484-494.
8. Chan, P. C., and Huff, J. (1997). Arsenic carcinogenesis in animals and in humans: Mechanistic, experimental, and epidemiological evidence. Environ. Carcinog. Ecotoxicol. Rev. 15, 83-122.
9. Chen, C. J., Chuang, Y. C., Lin, T. M., and Wu, H. Y. (1985). Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: High-arsenic artesian well water and cancers. Cancer Res. 45, 5895-5899.
10. Chen, C. J., Wu, M. M., Lee, S. S., Wang, J. D., Cheng, S. H., and Wu, H. Y. (1988). Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis 8, 452-460.
11. Chouchane, S., and Snow, E. T. (2001). In vitro effect of arsenical compounds on glutathione-related enzymes. Chem. Res. Toxicol. 14, 517-522.
12. Clarke, J. B., Fortes, M. A., Giovanni, A., and Brewster, D. W. (1996). Modification of an enzymatic glutathione assay for the microtiter plate and the determination of glutathione in rat primary cortical cells. Toxicol. Meth. 6, 223-230.
13. Davies, M. H., Birt, D. F., and Schnell, R. C. (1984). Direct enzymatic assay for reduced and oxidized glutathione. J. Pharmacol. Methods 12, 191-194.
14. Deaton, M. A., Bowman, P. D., Jones, G. P., and Powanda, M. C. (1990). Stress protein synthesis in human keratinocytes treated with sodium arsenite, phenyldichloroarsine, and nitrogen mustard. Fundam. Appl. Toxicol. 14, 471-476.
15. Henseleit, U., Rosenbach, T., and Kolde, G. (1996). Induction of apoptosis in human HaCaT keratinocytes. Arch. Dermatol. Res. 288, 676-683.
16. Hu, Y., Jin, X., and Snow, E. T. (2002). Effect of arsenic on transcription factor AP-1 and NF-kappaB DNA binding activity and related gene expression. Toxicol. Lett. 133, 33-45.
17. Huang, C., Ma, W. Y., Li, J., Goranson, A., and Dong, Z. (1999). Requirement of Erk, but not JNK, for arsenite-induced cell transformation. J. Biol. Chem. 274, 14595-14601.
18. Kitchin, K. T. (2001). Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172, 249-261.
19. Lee, T. C., and Ho, I. C. (1995). Modulation of cellular antioxidant defense activities by sodium arsenite in human fibroblasts. Arch. Toxicol. 69, 498-504.
20. Lee, T. C., Wei, M. L., Chang, W. J., Ho, I. C., Lo, J. F., Jan, K. Y., and Huang, H. (1989). Elevation of glutathione levels and glutathione S-transferase activity in arsenic-resistant Chinese hamster ovary cells. In Vitro Cell. Dev. Biol. 25, 442-448.
21. Lin, S., Cullen, W. R., and Thomas, D. J. (1999). Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem. Res. Toxicol. 12, 924-930.
22. Liu, J., Liu, Y., Goyer, R. A., Achanzar, W., and Waalkes, M. P. (2000). Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oval or injected inorganic arsenicals. Toxicol. Sci. 55, 460-467.
23. Liu, S. X., Athar, M., Lippai, I., Waldren, C., and Hei, T. K. (2001). Induction of oxyradicals by arsenic: Implication for mechanism of genotoxicity. Proc. Natl. Acad. Sci. U.S.A. 98, 1643-1648.
24. Lusini, L., Tripodi, S. A., Rossi, R., Giannerini, F., Giustarini, D., del Vecchio, M. T., Barbanti, G., Cintorino, M., Tosi, P., and Di Simplicio, P. (2001). Altered glutathione anti-oxidant metabolism during tumor progression in human renal-cell carcinoma. Int. J. Cancer 91, 55-59.
25. Maiti, S., and Chatterjee, A. K. (2000). Differential response of cellular antioxidant mechanism of liver and kidney to arsenic exposure and its relation to dietary protein deficiency. Environ. Toxicol. Pharmacol. 8, 227-235.
26. Matsui, M., Nishigori, C., Toyokuni, S., Takada, J., Akaboshi, M., Ishikawa, M., Imamura, S., and Miyachi, Y. (1999). The role of oxidative DNA damage in human arsenic carcinogenesis: Detection of 8-hydroxy-2′-deoxyguanosine in arsenic-related Bowen's disease. J. Invest. Dermatol. 113, 26-31.
27. Mazumder, D. N., Haque, R., Ghosh, N., De, B. K., Santra, A., Chakraborti, D., and Smith, A. H. (2000). Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. Int. J. Epidemiol. 29, 1047-1052.
28. Morales, A., Miranda, M., Sanchez-Reyes, A., Colell, A., Biete, A., and Fernandez-Checa, J. C. (1998). Transcriptional regulation of the heavy subunit chain of γ-glutamylcysteine symbetase by ionizing radiation. FEBS Lett. 427, 15-20.
29. Ochi, T. (1997). Arsenic compound-induced increases in glutathione levels in cultured Chinese hamster V79 cells and mechanisms associated with changes in γ-glutamylcysteine synthetase activity, cystine uptake and utilization of cysteine. Arch. Toxicol. 71, 730-740.
30. Ochi, T., Kaise, T., and Oya-Ohta, Y. (1994). Glutathione plays different roles in the induction of the cytotoxic effects of inorganic and organic arsenic compounds in cultured BALB/c 3T3 cells. Experientia 50, 115-120.
31. Parrish, A. R., Zheng, X. H., Turney, K. D., Younis, H. S., and Gandolfi, A. J. (1999). Enhanced transcription factor DNA binding and gene expression induced by arsenite or arsenate in renal slices. Toxicol. Sci. 50, 98-105.
32. Perquin, M., Oster, T., Maul, A., Froment, N., Untereiner, M., and Bagrel, D. (2001). The glutathione-related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features. J. Cancer Res. Clin. Oncol. 127, 368-74.
33. Pinkus, R., Weiner, L., and Daniel, V. (1996). Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression. J. Biol. Chem. 271, 13422-13429.
34. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
35. Santra, A., Maiti, A., Das, S., Lahiri, S., Charkaborty, S. K., and Mazumder, D. N. (2000). Hepatic damage caused by chronic arsenic toxicity in experimental animals. J. Toxicol. Clin. Toxicol. 38, 395-405.
36. Shi, M. M., Kugelman, A., Iwamoto, T., Tian, L., and Forman, H. J. (1994). Quinone-induced oxidative stress elevates glutathione and induces γ-glutamylcysteine synthetase activity in rat lung epithelial L2 cells. J. Biol. Chem. 269, 26512-26517.
37. Snow, E., Hu, Y., Yan, C., and Chouchane, S. (1999). Modulation of DNA repair and glutathione levels in human keratinocytes by micromolar arsenite. In Arsenic Exposure and Health Effects: Proceedings of the Third International Conference on Arsenic Exposure and Health Effects, July 12-15, 1998 (W. R. Chappell, C. O. Abernathy, and R. L. Calderon, Eds.), pp. 243-251. Elsevier Science, Oxford, UK.
38. Snow, E. T., Schuliga, M., Chouchane, S., and Hu, Y. (2001). Sub-toxic arsenite induces a multi-component protective response against oxidative stress in human cells. In Proceedings of 4th International Conference on Arsenic Exposure and Health Effects (W. R. Chappel, C. O. Abernathy, and R. Calderon, Eds.), pp. 265-275. Elsevier Science, San Diego, CA.
39. Styblo, M., Delnomdedieu, M., and Thomas, D. J. (1996). Mono- and dimethylation of arsenic in rat liver cytosol in vitro. Chem. Biol. Interact. 99, 147-164.
40. Styblo, M., Lin, S., Del Razo, L., and Thomas, D. (2001). Trivalent methylated arsenicals: Toxic products of the metabolism of inorganic arsenic. In Arsenic Exposure and Health Effects IV (W. R. Chappell, C. O. Abernathy, and R. L. Calderon, Eds.), pp. 325-337. Elsevier Science, London.
41. Styblo, M., Serves, S. V., Cullen, W. R., and Thomas, D. J. (1997). Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 10, 27-33.
42. Styblo, M., Vega, L., Germolec, D., Luster, M., Maria Del Razo, L., Wang, C., Cullen, W., and Thomas, D. (1999). Metabolism and toxicity of arsenicals in cultured cells. In Arsenic Exposure and Health Effects: Proceedings of the Third International Conference on Arsenic Exposure and Health Effects, July 12-15, 1998 (W. Chappell, C. Abernathy, and R. Calderon, Eds.), pp. 311-323. Elsevier Science, Oxford, U.K.
43. Tan, M., Li., S., Swaroop, M., Guan, K., Oberley, L. W., and Sun, Y. (1999). Transcriptional activation of the human glutathione peroxidase promoter by p53. J. Biol. Chem. 274, 12061-12066.
44. Tchounwou, P. B., Wilson, B. A., Ishaque, A. B., and Schneider, J. (2001). Atrazine potentiation of arsenic trioxide-induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2). Mol. Cell. Biochem. 222, 49-59.
45. Thomas, D. J., Styblo, M., and Lin, S. (2001). The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176, 127-144.
46. Tian, K., Norris, A., Lin, C. L., and Li, E. (1997). The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains. Biochemistry 36, 5669-5676.
47. Tseng, C. H., Chong, C. K., Chen, C. J., and Tai, T. Y. (1996). Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 120, 125-133.
48. Tseng, W. P., Chu, H. M., How, S. W., Fong, J. M., Lin, C. S., and Yeh, S. (1968). Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40, 453-463.
49. Vallis, K. A., and Wolf, C. R. (1996). Relationship between the adaptive response to oxidants and stable menadione-resistance in Chinese hamster ovary cell lines. Carcinogenesis 17, 649-654.
50. Wang, T. S., Kuo, C. F., Jan, K. Y., and Huang, H. (1996). Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J. Cell. Physiol. 169, 256-268.
51. Wong, S. S., Tan, K. C., and Goh, C. L. (1998). Cutaneous manifestations of chronic arsenicism: Review of seventeen cases. J. Am. Acad. Dermatol. 38, 179-185.
52. Yan, C. C., and Huxtable, R. J. (1995). Fluorimetric determination of monobromobimane and o-phthalaldehyde adducts of γ-glutamylcysteine and glutathione: Application to assay of γ-glutamylcysteinyl synthetase activity and glutathione concentration in liver. J. Chromatog. B Biomed. Appl. 672, 217-224.
53. Yu, R. C., Hsu, K. H., Chen, C. J., and Froines, J. R. (2000). Arsenic methylation capacity and skin cancer. Cancer Epidemiol. Biomark. Prev. 9, 1259-1262.